The upregulation of LRP1B, RGS5, STAT2, and HLA-A in SDR42E1-depleted cells suggests enhanced apoptotic singling, tumor-immune crosstalk, and immune recognition—aligning with vitamin D’s immunomodulatory roles and potentially increasing chemotherapy sensitivity (35–37). The gene discussed is LRP1B; the disease is neoplasm.